Expression of cytochrome P450 3A4 in foveolar epithelium with intestinal metaplasia of the human stomach

Japanese Journal of Cancer Research

Volumn 89, Issue 10, 1998, Pages 1028-1032

  Yokose, Tomoyuki ^a   Doy, Mikio ^b   Kakiki, Motoharu ^c   Horie, Tohru ^c   Matsuzaki, Yasushi ^d   Mukai, Kiyoshi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b Tsukuba Medical Center   (Japan)

^c EISAI CO LTD   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Cytochrome P450 3A4; Human; Intestinal metaplasia; Reverse transcription polymerase chain reaction; Stomach

Indexed keywords

CYTOCHROME P450 ISOENZYME; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; LIVER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYLORUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH EPITHELIUM; STOMACH FUNDUS;

EID: 0031759335     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00492.x     Document Type: Article

References (28)

1. Nelson, D. R., Kamataki, T., Waxman, D. J., Guengerich, F. P., Estabrook, R. W., Feyereisen, R., Gonzalez, F. J., Coon, M. J., Gunsalus, I. C., Gotoh, O., Okuda, K. and Nebert, D. W. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol., 12, 1-51 (1993).
2. Degawa, M., Stern, S. J., Martin, M. V., Guengerich, F. P., Fu, P. P., Ilett, K. F., Kaderlik, R. K. and Kadlubar, F. F. Metabolic activation and carcinogen-DNA adduct detection in human larynx. Cancer Res., 54, 4915-4919 (1994).
3. Kivistoe, K. T., Fritz, P., Linder, A., Friedel, G., Beaune, P. and Kroemer, H. K. Immunohistochemical localization of cytochrome P450 3A in human pulmonary carcinomas and normal bronchial tissue. Histochemistry, 103, 25-29 (1995).
4. Murray, M. and Reidy, G. F. Selectivity in the inhibition of mammalian cytochrome P-450 by chemical agents. Pharmacol. Rev., 42, 85-101 (1990).
5. Watkins, P. B., Wrighton, S. A., Maurel, P., Schetz, E. G., Mendez-Picon, G., Parker, G. A. and Guzelian, P. S. Identification of an inducible form of cytochrome P-450 in human liver. Proc. Natl. Acad. Sci. USA, 82, 6310-6314 (1985).
6. Miura, S. M., Mori, M., Takiguchi, M., Tatibana, M., Furuta, S., Miyazawa, S. and Hashimoto, T. Biosynthesis and intracellular transport of enzymes of peroxisomal beta-oxidation. J. Biol. Chem., 259, 6397-6402 (1984).
7. Peers, F. G. and Linsell, C. A. Dietary aflatoxins and liver cancer: population based study in Kenya. Br. J. Cancer, 27, 473-481 (1973).
8. Shank, R. C., Bhamarapravati, N., Gordon, J. E. and Wogan, G. N. Dietary aflatoxins and human liver cancer (IV): incidence in Thailand. Food Cosmet. Toxicol., 10, 171-179 (1972).
9. Hirota, T., Okada, T., Itabashi, M., Yoshida, H., Matsukura, H., Kitaoka, H. and Hirayama, T. Significance of intestinal metaplasia as a precancerous condition of the stomach. In "Precursors of Gastric Cancer," ed. S. C. Ming, pp. 179-193 (1984). Praeger, New York.
10. Matsukura, N., Suzuki, K., Kawachi, T., Aoyagi, M., Sugimura, T., Kitaoka, H., Numajiri, H., Shirota, A., Itabashi, M. and Hirota, T. Distribution of marker enzymes and mucin in intestinal metaplasia in human stomachs and relation of complete and incomplete types of metaplasia to minute gastric carcinoma. J. Natl. Cancer Inst., 65, 231-240 (1980).
11. Thummel, K. E., O'Shea, D., Paine, M. F., Shen, D. D., Kunze, K. L., Perkins, J. D. and Wilkinson, G. R. Oral fast-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism. Clin. Pharmacol. Ther., 59, 491-502 (1996).
12. Guengerich, F. P. Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res., 48, 2946-2954 (1988).
13. Hsu, S. M., Raine, L. and Fange, H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29, 577-580 (1981).
14. Kremers, P., Beaune, P., Cresteil, T., De Graeve, J., Columelli, S., Leroux, J. P. and Gielen, J. E. Cytochrome P-450 monooxygenase activity in human and rat liver microsomes. Eur. J. Biochem., 118, 599-606 (1981).
15. Laemmli, U. K. Cleavage of structural properties during the assembly of the head of bacteriophage T4. Nature, 227, 680-685 (1970).
16. Beaune, P., Flinois, J. P., Kiffel, L., Kremers, P. and Leroux, J. P. Purification of a new cytochrome P 450 from human liver microsomes. Biochim. Biophys. Acta, 860, 364-370 (1985).
17. Noonan, K. E. and Robinson, I. B. mRNA phenotyping by enzymatic amplification of randomly primed cDNA. Nucleic Acids Res., 16, 10366 (1988).
18. Gonzalez, F. J., Schmid, B. J., Umeno, M., McBride, O. W., Hardwick, J. P., Meyer, U. A., Gelboin, H. V. and Idle, J. R. Human p450PCN1: sequence, chromosomal localization, and direct evidence through cDNA expression that p450PCN1 is nifedipine oxidase. DNA, 7, 79-86 (1988).
19. Komori, M., Nishio, K., Ohi, H., Kitada, M. and Katamiki, T. Molecular cloning and sequence analysis of cDNA containing the entire coding region for human fetal liver cytochrome p450. J. Biochem., 105, 161-163 (1989).
20. Molowa, D. T., Schuetz, E. G., Wrighton, S. A., Watkins, P. B., Kremers, P., Mendez-Picon, G., Parler, G. A. and Guzelian, P. S. Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. Proc. Natl. Acad. Sci. USA, 83, 5311-5315 (1986).
21. Murray, G. I., Barnes, T. S., Sewell, H. F., Ewen, S. W. B., Melvin, W. T. and Burke, M. D. The immunohistochemical localization and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with monoclonal antibody to human cytochrome P-450. Br. J. Clin. Pharmacol., 25, 465-475 (1988).
22. Kolars, J. C., Lown, K. S., Schmiedlin-Ren, P., Ghosh, M., Fang, C., Wrighton, S. A., Merion, R. M. and Watkins, P. B. CYP3A gene expression in human gut epithelium. Pharmacogenetics, 4, 247-259 (1994).
23. Lee, H. S., Sarosi, I. and Vyas, G. N. Aflatoxin B1 formamidopyrimidine adducts in human hepatocarcinogenesis: a preliminary report. Gastroenterology, 97, 1281-1287 (1989).
24. Stemmermann, G. N. Intestinal metaplasia of the stomach: a status report. Cancer, 74, 556-564 (1994).
25. Ochiai, A. and Hirohashi, S. Genetic alterations in the precursors of gastric cancer. In "Molecular Pathology of Gastroenterological Cancer: Application to Clinical Practice," ed. E. Tahara, pp. 43-53 (1997). Springer-Verlag, Tokyo.
26. Kaminsky, L. S. and Fasco, M. J. Production and purification of antibodies to rat liver cytochrome P-450. Crit. Rev. Toxicol., 21, 407-122 (1992).
27. McKinnon, R. A. and McManus, M. E. Function and localization of cytochromes P450 involved in the metabolic activation of food-derived heterocyclic amines. Proc. 23rd Int. Symp. Princess Takamatsu Cancer Res. Fund, 145-153 (1995).
28. Kolars, J. C., Benedict, P., Schmiedlin-Ren, P. and Watkins, P. B. Aflatoxin B1-adduct formation in rat and human small bowel enterocytes. Gastroenterology, 106, 433-439 (1994).